Cargando…

SARS-CoV-2 antibody seroconversion in care home

Detalles Bibliográficos
Autores principales:	Shang, Joan, Moreira, Alvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530877/ https://www.ncbi.nlm.nih.gov/pubmed/33009507 http://dx.doi.org/10.1038/s41577-020-00463-1

Ejemplares similares

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego
por: Nicholson, Laura, et al.
Publicado: (2021)

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
por: Guven, Deniz C, et al.
Publicado: (2022)

SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)
por: van Bremen, Kathrin, et al.
Publicado: (2021)

SARS-CoV-2-specific T cells without antibodies
por: Bozkus, Cansu Cimen
Publicado: (2020)

Antibody responses to SARS-CoV-2 short-lived
por: Vabret, Nicolas
Publicado: (2020)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
por: Tuaillon, E, et al.
Publicado: (2020)

Available COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays.
por: Belda, Francisco, et al.
Publicado: (2021)

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies
por: Wong, Lydia Su Yin, et al.
Publicado: (2023)

Antibody response to SARS-CoV-2 — sustained after all?
por: Compeer, Ewoud B., et al.
Publicado: (2020)

Outliers Matter—Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
por: Hocher, Berthold, et al.
Publicado: (2022)

Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2
por: Marra, A., et al.
Publicado: (2021)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

SARS-CoV-2 variant evades antibodies whilst maintaining fitness
por: Flemming, Alexandra
Publicado: (2021)

A serological assay to detect SARS-CoV-2 seroconversion in humans
por: Amanat, Fatima, et al.
Publicado: (2020)

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures
por: Gonçalves, Juliana, et al.
Publicado: (2020)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children
por: Ahmed, Amina, et al.
Publicado: (2022)

A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions
por: Laing, Eric, et al.
Publicado: (2020)

Longitudinal SARS-CoV-2 Seroconversion Course and Antibody Levels by Blood Groups in Convalescent Plasma Donors in Turkey
por: Karaca, Aziz, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays
por: Yun, Sojeong, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls
por: Mathew, Hannah R, et al.
Publicado: (2021)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
por: Szewczyk-Dąbrowska, Alina, et al.
Publicado: (2022)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
por: Jay, Cecilia, et al.
Publicado: (2023)

Harmonization of Determination of SARS-CoV-2 Antibodies: Is It Always Possible?
por: Dittadi, Ruggero
Publicado: (2022)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD
por: Ray, Katrina
Publicado: (2021)

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
por: Jiang, Chuanhao, et al.
Publicado: (2020)

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
por: Houlihan, Catherine F, et al.
Publicado: (2020)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2dvlko69mf0ddmvs7kcokjr9cj